Give that poor survival of ovarian cancer is associated with chemoresistence, together with our findings, we can speculate that chemoresistance established by downregulation of LATS2 may explain the relation of miR-363upregulation with poor survival of ovarian cancer, albeit in part. Here, LATS2 is linked to ovarian carcinoma.